Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck adds regulatory unit to its research operations

Appoints Jens Peter Balling to lead the product support, patient safety and quality assurance unit

Danish pharma company Lundbeck has set up a new unit within its research operations to focus on regulatory product support, patient safety and quality assurance of clinical research.

It will be led by Jens Peter Balling, who has been appointed vice president of regulatory affairs, pharmacovigilance and clinical quality assurance within the company's R&D operations.

Balling has been with Lundbeck since 2006, when he joined as divisional director of global pharmacovigilance, and previously worked for Novo Nordisk and Nycomed.

He will be joined in the new unit by Iman Barilero, also newly appointed as vice president of regulatory development strategy and policy and who has a liaison role with regulatory authorities.

Anders Gersel Pedersen, Lundbeck's executive vice president of research and development, said: "The appointments of Jens Peter Balling and Iman Barilero reflect our efforts to build a strong and competent research and development organisation that enables us to continue to deliver results as we invest in the future. The regulatory and safety areas are an increasingly important prerequisite for this.

“The creation of one new unit and the increased focus on the other gives us a strong position in these areas.”

8th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics